Meet Stephen Chun, M.D.
Stephen G. Chun, MD
Department of Radiation Oncology, Division of Radiation Oncology
About Dr. Chun
Dr. Chun is a Radiation Oncologist practicing at the MD Anderson Proton Center and West Houston Campus and co-host of the NRG Oncology Podcast. As Director of Radiation Oncology Clinical Research for the MD Anderson Houston Area Locations, Dr. Chun led the expansion of the radiation oncology clinical trial program across the MD Anderson integrated academic satellite network and is supported by extramural grant funding from the National Institutes of Health as Principal Investigator. In the MD Anderson Houston Area Locations, Dr. Chun implemented the stereotactic body radiotherapy (SBRT) program for pancreatic cancer as well as the frameless stereotactic radiosurgery (SRS) program for brain metastases. With NRG Oncology, Dr. Chun is active with the Lung Core, Radiation Oncology and Protocol Operations Management Oversight Committees. As an active clinical researcher, Dr. Chun has published in journals such as the Lancet, the Journal of Clinical Oncology, the Journal of Thoracic Oncology and JAMA Oncology.
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2010 | University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii, US, MD |
| 2005 | Georgetown University, Washington, DC, US, Biology, BS |
Postgraduate Training
| 2015-2016 | Clinical Fellowship, The University of Texas M.D. Anderson Cancer Center, Houston, Texas |
| 2011-2015 | Clinical Residency, University of Texas at Southwestern Medical Center, Dallas, Texas |
| 2010-2011 | Clinical Internship, University of Hawaii, Honolulu, Hawaii |
| 2007-2008 | Doris Duke Clinical Research Fellowship, University of Iowa, Iowa City, Iowa |
Board Certifications
| 2016 | The American Board of Radiology, Radiation Oncology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2022
Administrative Appointments/Responsibilities
Director of Radiation Oncology Clinical Research for MD Anderson Houston Area Locations, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Other Appointments/Responsibilities
Consultant, Elsevier, Netherlands, 2023 - 2024
Consultant, Curio Science, Chicago, IL, 2022 - 2022
Consultant, Norton Healthcare, Inc, Louisville, KY, 2020 - 2020
Consultant, AstraZeneca, Wilmington,DE, 2019 - Present
Institutional Committee Activities
Member, Institutional Review Board (IRB), 2023 - Present
Member, Radiation Oncology Cancer Network Research Steering Committee, 2020 - Present
Member, Radiation Oncology Clinical Research Council, 2018 - Present
Member, MD Anderson Houston Area Locations Clinical Research Steering Committee, 2017 - 2021
Member, MD Anderson Cancer Center Department of Radiation Oncology Annual Training Program Evaluation Committee, 2015 - 2016
Member, MD Anderson Cancer Center GME House Staff Senate, 2015 - 2016
Honors & Awards
| 2025 | Annual Social Media Award - The NRG Oncology Podcast, American College of Radiation Oncology |
| 2025 | Top Doctor of 2025, Castle Connolly |
| 2024 | Faculty Excellence Award, MD Anderson |
| 2024 | Leadership Development Program, American Society of Clinical Oncology |
| 2024 | Top Doctor of 2024, Castle Connolly |
| 2023 | PRS CAHPS Top Performer Patient Care, Physician's Referral Service |
| 2023 | Top Doctor of Texas 2023, Castle Connolly |
| 2023 | Volunteer Service Award, American Board of Radiology |
| 2022 | Top Doctor of Texas 2022, Castle Connolly |
| 2017 | Best of Journal of Clinical Oncology Manuscript, American Society of Clinical Oncology (ASCO) |
| 2017 | Physician Referral Service CAHPS Top 1% Performer Patient Satisfaction, MD Anderson |
| 2016 | Outstanding Abstract, NRG Oncology |
| 2015 | Best of ASTRO Abstract, American Society for Radiation Oncology (ASTRO) |
| 2015 | William S. Roentgen Resident Research Award, Radiologic Society of North American (RSNA) and UT Southwestern Medical Center |
| 2014 | Resident Research Symposium Competition Winner, American Medical Association (AMA) |
| 2012 | Cover Image, Cancer Biology and Therapy; volume 13, issue 14 |
| 2010 | Award in Biomedical Research Excellence, University of Hawaii, John A. Burns School of Medicine |
| 2010 | Medical student research competition winner, University of Hawaii Biomedical Science Symposium, University of Hawaii, John A. Burns School of Medicine |
| 2010 | Resident Research Competition Winner, Hawaii Chapter of the American College of Surgery (ACS) |
| 2009 | Annual Meeting Medical Student Research Competition Winner, American College of Physicians (ACP) |
| 2009 | Cover Image, Cancer Biology and Therapy; volume 8, issue 14 |
| 2009 | Ellen M. Koenig Award in Medicine, Achievement Awards for College Scientists (ARCS) Foundation |
| 2009 | Medical Student Clinical Vignette Competition Winner, Society of General Internal Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2025. e-Pub 2025. PMID: 39486645.
- Ning, M, Odwuor, A, Chang, JY, Gandhi, S, Liao, Z, Lin, SH, Chen, A, Welsh, J, Nguyen, Q, O'Reilly, M, Chun, SG, Bronk, JK, Qian, DC, Lee, PP. Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers 16(21), 2024. e-Pub 2024. PMID: 39518028.
- Amini A, Zaha VG, Hamad E, Woodard PK, Rimner A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Higgins KA, Iyengar P, Juloori A, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB 2nd. American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy. J Thorac Oncol 19(12):1654-1667, 2024. e-Pub 2024. PMID: 39313150.
- Park HS, Rimner A, Amini A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Higgins KA, Iyengar P, Juloori A, Movsas B, Nemeth Z, Ning MS, Rodrigues G, Wolf A, Simone CB 2nd. Appropriate Use Criteria (AUC) for Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Executive Summary of the American Radium Society's Systematic Review and Guidelines. J Thorac Oncol 19(12):1640-1653, 2024. e-Pub 2024. PMID: 39271016.
- Chun SG, Hu C, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Kavadi VS, Narayan S, Iyengar P, Robinson C, Rothman J, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Long-term prospective outcomes of intensity modulated radiotherapy for locally-advanced lung cancer: A secondary analysis of a randomized clinical trial. JAMA Oncol 10(8):1111-1115, 2024. e-Pub 2024. PMID: 38935373.
- Rodrigues G, Higgins KA, Rimner A, Amini A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Iyengar P, Movsas B, Ning MS, Park HS, Wolf A, Simone CB. American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer. JAMA Oncol 10(6):799-806, 2024. e-Pub 2024. PMID: 38602670.
- Tate MK, Hernandez M, Chang JY, Lin SH, Liao Z, Koshy SM, Skinner HD, Chun SG. Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical Trial. Anticancer Res 44(1):133-137, 2024. e-Pub 2024. PMID: 38159979.
- Garg AK, Hernandez M, Schlembach PJ, Bowers JR, McAleer MF, Brown PD, Gopal R, Wiederhold L, Swanson T, Shah SJ, Li J, Ferguson SD, Philip NV, DeGracia L, Bloom ES, Chun SG. A phase II clinical trial of frameless fractionated stereotactic radiotherapy for brain metastases. JNCI Cancer Spectr 7(6), 2023. e-Pub 2023. PMID: 37944053.
- Cazacu IM, Singh BS, Martin-Paulpeter RM, Beddar S, Chun S, Holliday EB, Koong AC, Das P, Koay EJ, Taniguchi C, Herman JM, Bhutani MS. Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiation Therapy in Patients with Pancreatic Cancer. Cancers (Basel) 15(22), 2023. e-Pub 2023. PMID: 38001615.
- Chang JY, Lin SH, Dong W, Liao Z, Gandhi SJ, Gay CM, Zhang J, Chun SG, Elamin YY, Fossella FV, Blumenschein G, Cascone T, Le X, Pozadzides JV, Tsao A, Verma V, Welsh JW, Chen AB, Altan M, Mehran RJ, Vaporciyan AA, Swisher SG, Balter PA, Fujimoto J, Wistuba II, Feng L, Lee JJ, Heymach JV. Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial. Lancet 402(10405):871-881, 2023. e-Pub 2023. PMID: 37478883.
- Chun SG, Rimner A, Amini A, Chang JY, Donington J, Edelman MJ, Geng Y, Gubens MA, Higgins KA, Iyengar P, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB. American Radium Society Appropriate Use Criteria: Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma. JAMA Oncol 9(7):971-980, 2023. e-Pub 2023. PMID: 37186595.
- Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Cohen L, Aparicio A, Zurita AJ, Reuben A, Marmonti E, Chun SG, Reddy JP, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Pilie P, Kovitz C, Du W, Simiele SJ, Kumar R, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn PG. Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial. JAMA Oncol 9(6):825-834, 2023. e-Pub 2023. PMID: 37022702.
- Reddy JP, Lei X, Bloom ES, Reed VK, Schlembach PJ, Arzu I, Mayo L, Chun SG, Ahmad NR, Stauder MC, Gopal R, Kaiser K, Fang P, Smith BD, Investigators OT. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase II Tial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 115(3):629-644, 2023. e-Pub 2023. PMID: 36216274.
- Schild SE, Wang X, Bestvina CM, Williams T, Masters G, Singh AK, Stinchcombe TE, Salama JK, Wolf S, Zemla T, Duma N, Chun SG, Amini A, Kozono D, Watt C. Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clin Lung Cancer 23(5):e317-e320, 2022. e-Pub 2022. PMID: 35613998.
- Sherry AD, Bathala TK, Liu S, Fellman BM, Chun SG, Jasani N, Guadagnolo BA, Jhingran A, Reddy JP, Corn PG, Shah AY, Kaiser KW, Ghia AJ, Gomez DR, Tang C. Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results from the Lead-In Phase of the Randomized Basket Trial EXTEND. Int J Radiat Oncol Biol Phys 114(5):910-918, 2022. e-Pub 2022. PMID: 35691448.
- Corrigan KL, Lei X, Ahmad N, Arzu I, Bloom E, Chun SG, Goodman C, Hoffman KE, Joyner M, Mayo L, Mitchell M, Nead KT, Perkins GH, Reed V, Reddy JP, Schlembach P, Shaitelman SF, Stauder MC, Strom EA, Tereffe W, Wiederhold L, Woodward WA, Smith BD. Adoption of Ultrahypofractionated Radiation Therapy in Patients With Breast Cancer. Adv Radiat Oncol 7(2):100877, 2022. e-Pub 2022. PMID: 35387420.
- Amini A, Verma V, Simone CB, Chetty IJ, Chun SG, Donington J, Edelman MJ, Higgins KA, Kestin LL, Movsas B, Rodrigues GB, Rosenzweig KE, Rybkin II, Slotman BJ, Wolf A, Chang JY. American Radium Society™ Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 112(2):361-375, 2022. e-Pub 2022. PMID: 34571054.
- Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SH, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
- Gunn, GB, Garden, AS, Ye, R, Ausat, N, Dahlstrom, KR, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Shah, SJ, Mayo, LL, Chun, SG, Chronowski, G, Moreno, AC, Myers, JN, Hanna, EY, Esmaeli, B, Gillison, M, Ferrarotto, R, Hutcheson, KA, Chambers, MS, Ginsberg, LE, El-Naggar, AK, Rosenthal, D, Zhu, XR, Frank, SJ. Proton therapy for head and neck cancer. International Journal of Particle Therapy 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
- Gunn GB, Garden AS, Ye R, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, PHan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton therapy for head and neck cancer: A 12-year, single-institution experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 3425940.
- Zhou, N, Bott, M, Park, B, Vallieres, E, Wilshire, CL, Yasufuku, K, Spicer, JD, Jones, DR, Sepesi, B, Mitchell, KG, Corsini, EM, Antonoff, MB, Hofstetter, WL, Mehran, RJ, Rice, DC, Swisher, SG, Vaporciyan, AA, Walsh, GL, Huynh, C, Fiset, PO, Chun, SG, Gay, CM. Predictors of survival following surgical resection of limited-stage small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 161(3):760-771.e2, 2021. e-Pub 2021. PMID: 33349449.
- Augustyn A, Reed VI, Ahmad N, Bhutani MS, Bloom ES, Bowers JR, Chronowski GM, Das P, Holliday EB, Delclos ME, Huey RW, Koay EJ, Lee SS, Nelson CL, Taniguchi CM, Koong AC, Chun SG. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clin Transl Radiat Oncol 27:147-151, 2021. e-Pub 2021. PMID: 33665384.
- Gjyshi O, Xu T, Elhammali A, Boyce-Fappiano D, Chun SG, Gandhi S, Lee P, Chen AB, Lin SH, Chang JY, Tsao A, Gay CM, Zhu XR, Zhang X, Heymach JV, Fossella FV, Lu C, Nguyen QN, Liao Z. Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC. J Thorac Oncol 16(2):269-277, 2021. e-Pub 2021. PMID: 33198942.
- Thoracic Malignancies: EP, Higgins KA, Simone CB, Amini A, Chetty IJ, Donington J, Edelman MJ, Chun SG, Kestin LL, Movsas B, Rodrigues GB, Rosenzweig KE, Slotman BJ, Rybkin II, Wolf A, Chang JY. American Radium Society™ Appropriate Use Criteria on Radiation Therapy for Extensive-stage Small Cell Lung Cancer. J Thorac Oncol 16(1):54-65, 2021. e-Pub 2021. PMID: 33011389.
- Chun SG, Simone CB, Amini A, Chetty IJ, Donington J, Edelman MJ, Higgins KA, Kestin LL, Movsas B, Rodrigues GB, Rosenzweig KE, Slotman BJ, Rybkin II, Wolf A, Chang JY. American Radium Society™ Appropriate Use Criteria: Radiation Therapy for Limited-stage Small Cell Lung Cancer 2020. J Thorac Oncol 16(1):66-75, 2021. e-Pub 2021. PMID: 33166720.
- Barsoumian HB, Ramapriyan R, Younes AI, Caetano MS, Menon H, Comeaux NI, Cushman TR, Schoenhals JE, Cadena AP, Reilly TP, Chen D, Masrorpour F, Li A, Hong DS, Diab A, Nguyen QN, Glitza I, Ferrarotto R, Chun SG, Cortez MA, Welsh J. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. J Immunother Cancer 8(2):e00537, 2020. e-Pub 2020. PMID: 33106386.
- Patel RR, Verma V, Barsoumian H, Ning MS, Chun SG, Tang C, Chang JY, Lee PP, Gandhi S, Balter P, Dunn JD, Chen D, Puebla-Osorio N, Cortez AM, Welsh JW. Use of Multi-Site Radiation Therapy as Systemic Therapy: A New Treatment Approach Personalized by Patient Immune Status. Int J Radiat Oncol Biol Phys 109(2):352-364, 2020. e-Pub 2020. PMID: 32798606.
- Wakefield DV, Carnell M, Dove APH, Edmonston DY, Garner WB, Hubler A, Makepeace L, Hanson R, Ozdenerol E, Chun SG, Spencer S, Pisu M, Martin M, Jiang B, Punglia RS, Schwartz DL. Location as destiny: Identifying geospatial disparities in radiation treatment interruption by neighborhood, race, and insurance. Int J Radiat Oncol Biol Phys 107(4):815-826, 2020. e-Pub 2020. PMID: 32234552.
- Pezzi TA, Ning MS, Thaker NG, Boyce-Fappiano D, Gjyshi O, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko S, Gandhi S, Chun S, Tang C, Frank SJ, Gomez DR. Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing. Clin Transl Radiat Oncol 23:80-84, 2020. e-Pub 2020. PMID: 32529054.
- Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy versus Intensity Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol 38(14):1569-1579, 2020. e-Pub 2020. PMID: 32160096.
- Pezzi TA, Schwartz, DL, Pisters KMW, Mohamed ASR, Welsh JWW, Chang JY, Liao Z, Gandhi SJ, Byers LA, Minsky BD, Fuller CD, Chun SG. Association of Medicaid Insurance with survival among patients with small cell lung cancer. JAMA Netw Open 3(4), 2020. e-Pub 2020. PMID: 32320035.
- Chun SG, Liao Z, Jeter MD, Chang JY, Lin SH, Komaki RU, Guerrero TM, Mayo RC, Korah BM, Koshy SM, Heymach JV, Koong AC, Skinner HD. Metabolic responses to metformin in inoperable early-stage non-small cell lung cancer treated with stereotactic radiotherapy: results of a randomized Phase II clinical trial. Am J Clin Oncol 43(4):231-235, 2020. e-Pub 2020. PMID: 31990759.
- Lin JQ, Li SQ, Pezzi TA, Mohamed ASR, CDl F, Chen AB, Minsky BD, Schwartz DL, Hernandez BY, Chun SG. Veterans Affairs Insurance disparities for metastatic lung cancer in the Hawaiian Islands. JTO Clin Res Rep 1(1), 2020. e-Pub 2020. PMID: 34589910.
- Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong D, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer 7(1):237, 2019. e-Pub 2019. PMID: 31484556.
- Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol 58(8):1-3, 2019. e-Pub 2019. PMID: 30958082.
- Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. JAMA Oncol 5(6):872-878, 2019. e-Pub 2019. PMID: 31021390.
- Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG. Barriers to Combined-Modality Therapy for Limited-Stage Small-Cell Lung Cancer. JAMA Oncol 4(8):e174504, 2018. e-Pub 2018. PMID: 29302695.
- Schild SE, Sio TT, Daniels TB, Chun SG, Rades D. Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer. J Oncol Pract 13(11):732-738, 2017. e-Pub 2017. PMID: 29125923.
- Pezzi TA, Mohamed AS, Fuller CD, Blanchard P, Pezzi C, Sepesi B, Hahn SM, Gomez DR, Chun SG. Radiation Therapy is independently associated with worse survival after R0-resection for Stage I-II non-small cell lung cancer: an analysis of the National Cancer Data Base. Ann Surg Oncol 24(5):1419-1427, 2017. e-Pub 2017. PMID: 28154950.
- Chun SG, Hu C, Choy H, Komaki RU, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, MacRae RM, Paulus R, Bradley JD. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. J Clin Oncol 35(1):56-62, 2017. e-Pub 2017. PMID: 28034064.
- Chun SG, Hughes R, Sumer BD, Myers LL, Truelson JM, Khan SA, Ma TW, Xie Y, Yordy JS, Cooley S, Wu J, Choy H, Nedzi LA. A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck. Cancer Invest 35(1):23-31, 2017. e-Pub 2017. PMID: 27892728.
- Ding C, Chun SG, Sumer BD, Nedzi LA, Abdulrahman RE, Yordy JS, Lee P, Hrycushko B, Solberg TD, Ahn C, Timmerman RD, Schwartz DL. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer. Med Dosim 42(2):90-96, 2017. e-Pub 2017. PMID: 28438431.
- Schwartz DL, Sosa A, Chun SG, Ding C, Xie XJ, Nedzi LA, Timmerman RD, Sumer BD. SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial. PLoS One 12(3):e0172055, 2017. e-Pub 2017. PMID: 28253270.
- Samayoa AX, Pezzi TA, Pezzi CM, Greer Gay E, Asai M, Kulkarni N, Carp N, Chun SG, Putnam JB. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients. Ann Surg Oncol 23(Suppl 5):1005-1011, 2016. e-Pub 2016. PMID: 27531307.
- Li LS, Reddy S, Lin ZH, Liu S, Park H, Chun SG, Bornmann WG, Thibodeaux J, Yan J, Chakrabarti G, Xie XJ, Sumer BD, Boothman DA, Yordy JS. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer. Mol Cancer Ther 15(7):1757-67, 2016. e-Pub 2016. PMID: 27196777.
- Tokita M, Kennedy SR, Risques RA, Chun SG, Pritchard C, Oshima J, Liu Y, Bryant-Greenwood PK, Welcsh P, Monnat RJ. Werner syndrome through the lens of tissue and tumour genomics. Sci Rep 6:32038, 2016. e-Pub 2016. PMID: 27559010.
- Chun SG, Park H, Pandita RK, Horikoshi N, Pandita TK, Schwartz DL, Yordy JS. Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers. Am J Cancer Res 5(4):1337-52, 2015. e-Pub 2015. PMID: 26101701.
- Jacobs CD, Chun SG, Yan J, Xie XJ, Pistenmaa DA, Hannan R, Lotan Y, Roehrborn CG, Choe KS, Kim DW. Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy. Cancer Biol Ther 15(6):699-706, 2014. e-Pub 2014. PMID: 24658086.
- Chun SG, Nedzi LA, Choe KS, Abdulrahman RE, Chen SA, Yordy JS, Timmerman RD, Kutz JW, Isaacson B. A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors). Stereotact Funct Neurosurg 92(3):153-9, 2014. e-Pub 2014. PMID: 24818638.
- Chun SG, Choe KS, Iyengar P, Yordy JS, Timmerman RD. Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?. Cancer Biol Ther 13(14):1376-83, 2012. e-Pub 2012. PMID: 22986231.
- Yee NS, Zhou W, Chun SG, Liang IC, Yee RK. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer. Biol Open 1(4):295-307, 2012. e-Pub 2012. PMID: 23213420.
- Chun SG, Yee NS, Holland JM, Shohet RV, Palalay MP, Bryant-Greenwood PK. Pancreatic Adenocarcinoma Associated With Werner's Syndrome (Adult-Onset Progeria). Gastrointest Cancer Res 4(1):24-8, 2011. e-Pub 2011. PMID: 21464868.
- Chun SG, Pedro P, Yu M, Takanishi DM. Type IV Ehlers-Danlos Syndrome: A Surgical Emergency? A Case of Massive Retroperitoneal Hemorrhage. Open Cardiovasc Med J 5:210-211, 2011. e-Pub 2011. PMID: 21966332.
- Chun SG, Armstrong JA, Pang DK, Lau J, Shohet RV. Giant coronary artery aneurysms in a Japanese octogenarian - The oldest case of Kawasaki Disease?. J Cardiol Cases 1(2):e80-e83, 2010. e-Pub 2010. PMID: 23997839.
- Chun SG, Zhou W, Yee NS. Targeting histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer. Cancer Biol Ther 8(14):1328-39, 2009. e-Pub 2009. PMID: 19421011.
Invited Articles
- Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol 7:201, 2017. e-Pub 2017. PMID: 28929085.
Manuals, Teaching Aids, Other Teaching Publications
- Antonoff MB, Chun SG. Thymoma and Thymic Cancer. Elsevier ClinicalKey, 2024.
Other Articles
- Said BI, Geng Y, Badiyan SN, Bang A, Bezjak A, Chua KLM, Faivre-Finn C, Kong FM, Przybysz D, Putora PM, Munoz-Schuffenegger P, Siva S, Xu-Welliver M, McDonald F, Louie A, Chun SG Accelerated hypofractionated radiotherapy for locally-advanced non-small cell lung cancer: A systematic review from the International Association for the Study of Lung Cancer (IASLC) Advanced Radiation Technology (ART) Subcommittee. J Thorac Oncol 20(1):39-51, 2024. PMID: 39349294.
- Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab. Front Oncol 9:223, 2019. PMID: 31024834.
- Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol 10:193, 2019. PMID: 30828330.
- Bloom BC, Augustyn A, Sepesi B, Patel S, Shah SJ, Komaki RU, Schild SE, Chun SG Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature. Front Oncol 7:228, 2017. PMID: 29034208.
- Chun SG, Iyengar P, Gerber DE, Hogan RN, Timmerman RD Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation. J Clin Oncol 33(5):e25-6, 2015. PMID: 24616318.
- Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas J, Timmerman RD Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther 16(5):657-61, 2015. PMID: 25800036.
- Chun SG, Shaeffer DS, Bryant-Greenwood PK The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging. Hawaii Med J 70(3):52-5, 2011. PMID: 21365542.
- Chun SG, Yee NS Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy. Cancer Biol Ther 10(5):430-7, 2010. PMID: 20657174.
- Chun SG, Harada GL, Kuriyama DK, Nywening TM, Shohet RV Broken heart syndrome--a critical review of transient left ventricular apical ballooning. Hawaii Med J 66(10):265-7, 2007. PMID: 18065123.
- Chun SG, Kwok V, Pang DK, Lau TK Transient left ventricular apical ballooning syndrome (takotsubo cardiomyopathy) as a complication of permanent pacemaker implantation. Int J Cardiol 117(1):e27-30, 2007. PMID: 17289181.
Book Chapters
- Chun, SG, Reed, VK, Thomas, CR, Mitin, T. Radiation oncology career development in an academic satellite network, 189-200, 2021.
- Chun SG, Reed VI, Thomas CR, Mitin T. Radiation Oncology Career Development in an Academic Satellite Network. In: Career Development in Academic Radiation Oncology. 1. Springer, 189-200, 2021.
- Sepesi B, Cascone T, Chun SG, Altan M, Le X. Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer. In: Surg Oncol Clin N Am. 4, 555-569, 2020.
- Verma V, Chun SG, Thomas CR. Uncommon thoracic tumors. In: Gunderson and Tepper, Clinical Radiation Oncology, Fifth Edition. Elsevier, 2020.
- Chun SG, Skinner HD, Minsky BD. Radiation Therapy for Locally Advanced Esophageal Cancer. In: Surg Oncol Clin N Am. 2, 257-276, 2017.
Letters to the Editor
- Chun SG, Klopp AH. Meeting the burden of proof to justify intensity-modulated radiation for brain metastases. J Clin Oncol 38: 3452, 2020.
- Chun SG, Schild SE, Bogart JA. Time to Change the Limited-Stage Paradigm for Small Cell Lung Cancer?. JAMA Oncol 5: 1229.
- Chun SG, Pezzi TA, Schwartz DL. Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer-Reply. JAMA Oncol 4: 1436-1437.
- Chun SG, Hu C, Bradley JD. In Reply to Ball et al. J Clin Oncol 35: 1493-1494.
Selected Presentations & Talks
Local Presentations
- 2017. Update on radiation therapy for small cell lung cancer. Invited. Houston, Texas, US.
Regional Presentations
- 2025. Small Cell Lung Cancer. Invited. Radiation Oncology Residents - Grand Rounds (Virtual). San Antonio, TX, US.
- 2024. Developing a radiation oncology clinical research program in an integrated academic satellite. Invited. University of New Mexico - HemOnc Grand Rounds. Albuquerque, NM, US.
- 2024. Treatment Paradigm Changes for Non-Small Cell Lung Cancer. Visiting. Visiting Professorship Series. San Antonio, TX, US.
- 2017. Chemoradiation for locally-advanced non-small cell lung cancer. Invited. Radiation Oncology. Temple, TX, US.
National Presentations
- 2025. Clinical Research in an Integrated Satellite Network. Visiting. Visiting Professor Lecture. Philadelphia, PA, US.
- 2024. Clinical Research in an Integrated Satellite Network. Visiting. Grand Rounds. Albuquerque, New Mexico, US.
- 2024. Developing a radiation oncology clinical research program in an integrated academic satellite network. Visiting. Radiation Oncology Grand Rounds. Tampa, FL, US.
- 2024. NRG Radiation Oncology Committee - Disease Site Reports - Updates on concepts near development: Lung. Invited. NRG Radiation Oncology. Orlando, FL, US.
- 2023. Lung/Mediastinum Case Based Multidisciplinary Review. Invited. Radiological Society of North America (RSNA) 2023 Annual Meeting. Chicago, IL, US.
- 2023. Cardiothoracic Tumor Board. Invited. Society of Advanced Body Imaging (SABI) 2023 Annual Meeting. Dallas, TX, US.
- 2023. Developing a radiation oncology clinical research program in an integrated academic satellite network. Visiting. University of Tennessee Health Science Center - Cancer Center Grand Rounds. Memphis, TN, US.
- 2023. Role of RT in Thymoma and Thymic Malignancies. Invited. Multidisciplinary Thoracic Oncology Symposium: Patient-centered approach to improving outcomes. San Diego, CA, US.
- 2022. Lung/Mediastinum Case-based Multidisciplinary Review. Invited. Radiological Society of North America (RSNA) 2022 Annual Meeting. Chicago, IL, US.
- 2022. The importance of radiation conformity lung cancer: IMRT and the fallacy of the low dose bath. Visiting. 2022 Radiation Oncology Grand Rounds. Miami, FL, US.
- 2022. An overview of Lung Cancer Radiotherapy including SBRT Patient Selection. Invited. Merck. Chicago, IL, US.
- 2022. The importance of radiation conformity for locally-advanced non-small cell lung cancer: IMRT and the fallacy of the low dose bath. Visiting. Radiation Oncology Grand Rounds. Detroit, MI, US.
- 2021. Lung, Mediastinum, Pleura - Case-based Multidisciplinary Review. Invited. Radiologic Society of North America (RSNA). Chicago, IL, US.
- 2021. Radiation Therapy for Limited-Stage Small Cell Lung Cancer Guideline. Invited. ARS Appropriate Use Criteria (AUC) Thoracic Committee. Mount Royal, NJ, US.
- 2020. Proton Therapy for Hepatocellular Carcinoma. Invited. Extension for Community Healthcare Outcomes, Japan Team Oncology Program, US.
- 2019. Thoracic radiation oncology e-contouring. Invited. RSNA Annual Meeting. Chicago, IL, US.
- 2019. Metabolic responses to metformin in inoperable early-stage non-small cell lung cancer treated with stereotactic radiotherapy: results of a randomized Phase II clinical trial. Conference. IASLC North America Conference on Lung Cancer. Chicago, IL, US.
- 2019. Medicaid outcome inequalities in small cell lung cancer. Conference. IASLC North America Conference on Lung Cancer. Chicago, IL, US.
- 2019. The Impact of Medicaid Insurance on Treatment and Outcomes in Limited-Stage Small Cell Lung Cancer. Conference. ASTRO Annual Meeting. Chicago, IL, US.
- 2019. Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer. Conference. ASTRO Annual Meeting. Chicago, IL, US.
- 2018. Update on radiation therapy for small cell lung cancer. Invited. Radiation Oncology Residency Virtual Didactic Session. San Francisco, CA, US.
- 2018. Advances in non-small cell lung cancer management. Invited. Cuero, TX, US.
- 2018. An academic perspective on the MD Anderson satellite network. Invited. Society of Chairs of Academic Radiation Oncology Programs. Washington, DC, US.
- 2017. Major Drivers of Combined Modality Therapy for Limited-Stage Small Cell Lung Cancer in the United States National Cancer Database. Conference. IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology. Chicago, IL, US.
- 2015. Comparison of 3D-conformal and intensity modulated radiotherapy outcomes for locally-advanced non-small cell lung cancer in NRG Oncology/RTOG 0617. Conference. ASTRO Annual Meeting. San Antonio, TX, US.
- 2015. Predicting outcomes of chemoradiation for locally-advanced non-small cell lung cancer. Invited. Radiation Medicine. Portland, OR, US.
- 2015. Dosimetric analysis of 10 fraction stereotactic radiation therapy for early-stage glottic larynx cancer. Conference. American College of Radiation Oncology (ACRO) Annual Meeting. Washington, DC, US.
- 2014. Initial report of feasibility and toxicity of a Phase I accelerated hemilarynx stereotactic radiotherapy study for early-stage glottic larynx cancer. Conference. American Medical Association (AMA) Interim Meeting. Dallas, TX, US.
- 2014. Simultaneous targeting of histone deacetylases (HDAC) and the hedgehog (HH)-pathway causes synergistitic p53-independent p21waf up-regulation and radiation lethality in head and neck cancer. Conference. ASTRO Annual Meeting. San Francisco, US.
- 2011. Translation from bedside-to-bench: The WRN RecQ helicase at the nexus of cancer and aging, DNA repair and mesothelial carcinogenesis. Conference. American Society of Radiation Oncology (ASTRO) Translational Meeting. Atlanta, GA, US.
- 2011. Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in pancreatic cancer. Conference. AACR Annual Meeting. Orlando, FL, US.
- 2009. Combined targeting of histone deacetylases and hedgehog signaling enhances cytotoxicity in pancreatic cancer. Invited. Radiation Medicine. Portland, OR, US.
International Presentations
- 2024. Lung and esophageal cancer: Particle Therapy to reduce cardiac exposure in thoracic malignancies. Invited. 62nd Annual PTCOG Conference & 4th PTCOG-AO Meeting Plenary Session. Singapore, SG.
- 2024. Radiation in the Management of Small Cell Lung Cancer. Invited. Canadian Lung Cancer Conference 2024. Vancouver, CA.
- 2023. Long-term outcomes by radiation technique for locally-advanced non-small lung cancer: A secondary analysis of NRG Oncology-RTOG 0617 at 5-years. Invited. International Association for the Study of Lung Cancer (IASLC), SG.
- 2022. Advanced Radiation Technology in the Management of Locally-Advanced Pancreatic Cancer. Invited. Japanese Society for Radiation Oncology (JASTRO). Hiroshima, JP.
- 2021. The importance of radiation conformity for locally-advanced lung cancer: IMRT and the fallacy of the low dose bath. Invited. 8th Hong Kong International Oncology Symposium: Controversies in Precision Oncology. Hong Kong, HK.
- 2021. Radiation implications for the definitive management of locally-advanced lung cancer. Invited. International Association for the Study of Lung Cancer, US.
- 2017. Major Drivers of chemotherapy and radiation Utilization for limited-stage small cell lung cancer in the United States. Conference. IASLC World Lung Conference. Yokohama, JP.
- 2017. Prevalence and predictors of adjuvant radiation therapy for early-stage non-small cell lung cancer after margin-negative surgical resection in the National Cancer Data Base. Conference. ASCO Multidisciplinary Thoracic Symposium. San Francisco, US.
- 2016. V Update Symposium in Radiation Oncology - Multidisciplinary Symposium of Radiotherapy. Invited. Albert Einstein Hospital. Sao Paulo, BR.
- 2015. Outcomes of intensity modulated and 3D-conformal radiotherapy for Stage III non-small cell lung cancer. Conference. International Association for the Study of Lung Cancer (IASLC). Denver, US.
- 2014. The effects of anticoagulant use in high-risk prostate cancer on overall survival. Conference. ASCO Genitorurinary Cancers Symposium. San Francisco, US.
Grant & Contract Support
| Date: | 2023 - 2028 |
| Title: | A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1 R50 CA275822-01 |
| Date: | 2022 - 2026 |
| Title: | REStoring lymphoCytes Using NKTR-255* after chemoradiotherapy in lung cancer (RESCUE) |
| Funding Source: | Nektar Therapeutics |
| Role: | Collaborator |
| ID: | 00014687 |
| Date: | 2021 - 2023 |
| Title: | Institutional Funding Award for Federally Supported Clinical Trials (IFSCT) |
| Funding Source: | MD Anderson |
| Role: | Principal Investigator-MDACC |
Patient Reviews
CV information above last modified March 20, 2025